120
Participants
Start Date
December 2, 2019
Primary Completion Date
December 7, 2021
Study Completion Date
March 23, 2022
EscharEx (5% EX-02 formulation)
Active arm
Gel Vehicle
Control arm
Non-surgical standard of care (NSSOC)
Santyl (Enzymatic debridement) or commercially approved Hydrogel
Hopitaux Universitaires de Geneva, Geneva
Mount Sinai St. Luke's Hospital, New York
NYU Winthrop Hospital, Mineola
Stony Brook University Hospital, Stony Brook
Medstar Health Georgetown University, Washington D.C.
INTEGRAL - Clinical Trials Solutions, Doral
C & R Research Services USA, Inc, Coral Gables
University of Miami, Miami
Barry University Clinical Research, Miami Beach
AZH Wound Center, Milwaukee
Northwestern University, Chicago
Advanced Foot & Ankle Center, Las Vegas
Felix Sigal. D.P.M, PC, Los Angeles
ILD Research Center, Carlsbad
Limb Preservation Platform, Inc., Fresno
Stanford, Redwood City
Center for Clinical Research Inc., San Francisco
Massachusetts General Hospital, Boston
Boston Medical Center/Boston University Medical Center, Boston
South Shore Health System, Center for Wound Healing, Weymouth
Atlantic Health System - Overlook Wound Care Center, Summit
Bey Lea Ambulatory Surgical Center, Toms River
Lead Sponsor
MediWound Ltd
INDUSTRY